<DOC>
	<DOCNO>NCT03078231</DOCNO>
	<brief_summary>More 29 million people US live diabetes , many develop diabetic retinopathy ( DR ) diabetic eye disease ( DED ) , lead cause vision loss blindness working-age adult . Annual eye screen recommend diabetic patient since vision loss prevent laser photocoagulation anti-VEGF injection DR diagnose early stage . Currently , number clinical personnel train DR screen order magnitude small need screen large , grow diabetic population . Therefore , meet large unmet need DR screening , fully-automated computerized DR screening system necessary . This study design assess performance EyeArt , automate DR screen tool .</brief_summary>
	<brief_title>Pilot Assessment EyeArt Automated Diabetic Retinopathy Screening Tool</brief_title>
	<detailed_description />
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Mydriatics</mesh_term>
	<criteria>18 year age old ; diagnosis diabetes mellitus ; understand study provision write informed consent . Persistent visual impairment sudden vision loss one eye ; History uncorrected medium opacity one eye ; History retinal vascular disease diabetic eye disease ; History ocular injection , laser treatment retina , intraocular surgery cataract ; Subject contraindication mydriatic medication unwilling unable dilate ; Subject currently enrol interventional study investigational device/drug ; Subject condition situation opinion Investigator , might confound study result , may interfere significantly subject 's participation study , result ungradable 4wide field stereoscopic mydriatic fundus photograph .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>